Clinical Experience of Memantine in Alzheimer’s Disease

European Neurological Review - United Kingdom
doi 10.17925/enr.2008.03.02.22
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

Memantine Prodrug as a New Agent for Alzheimer’s Disease

Scientific Reports
Multidisciplinary
2019English

Developing Effective Alzheimer’s Disease Therapies: Clinical Experience and Future Directions

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2019English

Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer’s Disease

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2012English

Depressive Symptoms in Clinical and Incipient Alzheimer’s Disease

Neurodegenerative disease management
MedicineNeurology
2013English

Alzheimer’s Disease: Initial Clinical Implementation of Automated Volumetry

Canadian Journal of Neurological Sciences
MedicineNeurology
2014English

Tau Imaging in Alzheimer’s Disease Diagnosis and Clinical Trials

Neurotherapeutics
NeurologyPharmacology
2016English

Clinical, Biological, and Imaging Features of Monogenic Alzheimer’s Disease

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Persistent Treatment With Cholinesterase Inhibitors and/or Memantine Slows Clinical Progression of Alzheimer Disease

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2009English

Progresses in Treating Agitation: A Major Clinical Challenge in Alzheimer’s Disease

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy